Plasmodium vivax malaria relapses after primaquine prophylaxis [5]

Emerging Infectious Diseases

Volumn 12, Issue 11, 2006, Pages 1795-1796

  Reddy, Pavani ^a   Flaherty, John P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DOXYCYCLINE; PRIMAQUINE; QUININE;

ANAMNESIS; BRAZIL; CLINICAL FEATURE; DRUG MEGADOSE; HUMAN; LABORATORY TEST; LETTER; MALARIA; PHYSICAL EXAMINATION; PLASMODIUM VIVAX; PROPHYLAXIS; SINGLE DRUG DOSE; SOUTH AMERICA; SYMPTOMATOLOGY; TREATMENT FAILURE;

EID: 33750538856     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1211.060613     Document Type: Letter

References (5)

1. Ehrman FC, Ellis JM, Young MD. Plasmodium vivax Chesson strain. Science. 1945;101:377.
2. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis. 2004;39:1336-45.
3. Duarte EC, Pang LW, Ribeiro LC, Fontes CJ. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am J Trop Med Hyg. 2001;65:471-6.
4. Nayar JK, Baker RH, Knight JW, Sullivan JS, Morris CL, Richardson BB, et al. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys. J Parasitol. 1997;83:739-44.
5. Kim YR, Kuh HJ, Kim MY, Kim YS, Chung WC, Kim SI, et al. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria. Arch Pharm Res. 2004; 27:576-80.